Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) Invested Capital (2016 - 2025)

Cross Country Healthcare's Invested Capital history spans 16 years, with the latest figure at $322.8 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 23.75% year-over-year to $322.8 million; the TTM value through Dec 2025 reached $322.8 million, down 23.75%, while the annual FY2025 figure was $322.8 million, 23.75% down from the prior year.
  • Invested Capital reached $322.8 million in Q4 2025 per CCRN's latest filing, down from $408.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $480.4 million in Q2 2023 to a low of $173.7 million in Q1 2021.
  • Average Invested Capital over 5 years is $388.2 million, with a median of $420.8 million recorded in 2024.
  • Peak YoY movement for Invested Capital: soared 110.07% in 2022, then dropped 23.75% in 2025.
  • A 5-year view of Invested Capital shows it stood at $301.8 million in 2021, then skyrocketed by 52.1% to $459.0 million in 2022, then increased by 3.37% to $474.4 million in 2023, then dropped by 10.77% to $423.4 million in 2024, then fell by 23.75% to $322.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Invested Capital are $322.8 million (Q4 2025), $408.1 million (Q3 2025), and $412.2 million (Q2 2025).